U.S. Markets close in 1 hr 15 mins

Why Abbott Laboratories Shot Higher Today

·2 min read
Why Abbott Laboratories Shot Higher Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Abbott Laboratories (NYSE: ABT) easily surmounted Hump Day, rising by 3.4% and trouncing the S&P 500 index's gain as it did so. For the quarter, Abbott posted year-over-year sales growth of 23%, as its top line landed at $10.9 billion. Collectively, prognosticators tracking the healthcare company estimated that it would earn a bit more than $9.4 billion on the top line and post an adjusted net profit of $0.93.